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Ping Hu1†, Yan Wang1†, Lu-lu Meng1, Ling Qin1, Ding-yuan Ma1, Long Yi2 and Zheng-feng Xu1*Abstract
The reports of 1q25-32 deletion cases are rare. We reported here an 11-year-old Chinese Han female with an
interstitial 1q25 deletion displaying mental retardation, clinodactyly of the 5th finger and minor facial anomalies.
Notably, the patient did not present growth retardation which is quite common in patients with 1q25-32 deletion
encompassing LHX4. The heterozygous deletion in this patient was characterized as 46,XX,del(1)(q25.2-q31.3) with a
length of 20.5 Mb according to SNP-array test results. STRP (Short Tandem Repeat Polymorphism) analysis of the
family trio indicated the genomic abnormality was de novo with paternal origin. After a genotype-phenotype
analysis, we proposed here the loss of a 3.1 Mb critical region including 24 genes within 1q25.2 (chr1:174.5-177.6 Mb,
build 36) may account for the mental retardation in patients with 1q25-32 deletion.
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The reports of chromosome 1q deletion have been rela-
tively rare. Based on the deletion region, interstitial 1q
deletions are conventionally classified into three catego-
ries: proximal (1q21-22q25), intermediate (1q24-25q32),
and distal (1q42-43qter) deletion [1]. Up to date, about
25 intermediate 1q25-q32 deletion cases have been doc-
umented, of which, only 15 cases [2-12] were well charac-
terized using high-resolution molecular methods to map
the accurate deletion sizes. In the current study, a hetero-
zygous 1q25.2-q31.3 deletion in a female of 11-year-old
presenting mental retardation but no apparent growth
delay was characterized by SNP-array.
Clinical report
The proband, an 11-year-old Chinese Han girl, is the first
child born to healthy and non-consanguineous 25-year-old
mother and 24-year-old father. She was delivered at 39
weeks of gestation by cesarean due to fetal distress. The
pregnancy was uneventful with normal ultrasound and* Correspondence: njxzf@126.com
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reproduction in any medium, provided the orserum examinations reports throughout the pregnancy.
The patient was born with a weight of 2,730 g (−1.3SD), a
length of 48 cm (−1.1SD), a head circumference (OFC) of
35 cm (+0.9SD), and Apgar score of 10 at 1 minute and 10
at 5 minutes. Birth weights of the father and mother were
2,680 g (−1.55SD) and 3,000 g (−0.5SD) while birth lengths
and OFC were unavailable. The mother was a clerk and
the father was a businessman, both with high school dip-
loma as a terminal degree. There was no intellectual dis-
ability history in the family.
She rolled over at 4 months, sat without support at
7 months, crawled at 9 months. Psychomotor retardation
was recognized due to her delayed walking when she was
18 months old. She spoke her first words at age of 4.5 years
after a special training. At the age of 9, she was evaluated
with a full scale IQ of 49, performance IQ of 53 and verbal
IQ of 54 by Wechsler Intelligence Scale for Children.
The proband was referred to our genetic diagnosis
center when she was 11 years old. Her weight was 23 kg
(−1.74SD), height 134 cm (−1.67SD), and OFC 52 cm
(−0.6SD), without apparent growth retardation. The father
was 68 kg (+1.72SD) in weight and 169 cm (+0.12SD) in
height at age of 35, and the mother was 55 kg (+0.76SD)
and 159 cm (+0.34SD) at age of 36. The anticipated mid-
parental height of the patient was 157.5 cm (+0.07SD), inThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and feet sizes were in an ordinary range (25th-75th per-
centile), with a palmar length of 8.5 cm, middle finger
length 6.3 cm and foot length 20.5 cm. Minor anomalies
including prominent forehead, upslanting palpebral fissures,
short philtrum (philtrum length 1.1 cm, < 3th percentile),
everted upper lip, low posterior hairline, hypertelorism
(inner canthal distance 3.7 cm, > 97th percentile), broad
and depressed nasal bridge, arched eyebrows (Figure 1a) as
well as bilateral clinodactyly of 5th finger were observed.
Her palate appeared normal without clefts, and there was
no thyromegaly or congenital webbed neck. Neither hear-
ing impairment nor otitis media was found. Ophthalmo-
logic examination results were normal. Heart murmurs
were not detected via cardiac auscultation. Radiographic
examination confirmed bilateral clinodactyly of 5th finger,
and no abnormalities were found on phalanges or metacar-
pals. Her bone age was consistent with the chronological
age. The spine didn´t show any distinctive radiographic re-
sults. Electroencephalograph showed an abnormal brain-
wave activity, mainly focusing on wave θ. Ultrasonography
results indicated her uterus and ovaries were normal in size
and other internal organs including liver, spleen, pancreas
and kidneys appeared normal. Head magnetic resonanceFigure 1 Identification of a 1q25.2-31.3 deletion in the proband. a: Fa
forehead, upslanting palpebral fissures, short philtrum, everted upper lip, h
Two homologous chromosomes 1 of the patient. c: SNP-array analysis reve
length of 20.5 Mb. d: Competitive fluorescent multiplex STRP assay demon
sites D1S238 (chr1: 186412815–186413111), D1S218 (chr1: 172769757–1727
analyzed, results of D1S238 indicated the loss of the paternal allele in the fimaging and two-dimensional echocardiography did not
reveal any anomaly. Serum GH, TSH, fT3, and fT4 levels
were all in normal range. She was unable to dress herself.
She spoke with a lisp and had trouble in communication.
This work was approved by the Medicine Ethics Commit-
tee of Nanjing Maternity and Child Health Care Hospital
and the proband's legal guardian signed informed consent.
Results
Cytogenetic analysis
GTG-banding on the patient’s peripheral blood lympho-
cytes revealed an interstitial 1q deletion, the karyotype
was designated as 46,XX,del(1)(q25-q31) (Figure 1b). The
karyotypes of the parents were normal.
SNP-array and STRP analysis
A 20.5Mb deletion (chr1:174,592,050-195,122,910, build
36) within 1q25.2-q31.3 was detected from the patient’s
sample (Figure 1c). SNP-array analysis on the parents did
not reveal any pathological CNV (copy number variation),
indicating the deletion was de novo. SNP genotyping ana-
lysis of the family trio was performed to explore the paren-
tal origin of the deleted 1q25.2q31.3 fragment. Additional
file 1: Table S1 listed representative 29 sites selected fromcial image of the patient at the age of 11. She showed prominent
ypertelorism, broad and depressed nasal bridge, arched eyebrows. b:
aled a 1q deletion spanning from 174,592,050-195,122,910 with a
strated the deletion was of paternal origin. Three high informative STR
70032) and D1S413 (chr1:196887255–196887453) and G6PDH were
emale.
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the breakpoints, presenting different genotypes between
the parents. Based on the data from these homozygote
SNP sites, we concluded the lost allele was of paternal ori-
gin. Microsatellite analysis using D1S413, D1S218 and
D1S238 also confirmed the deletion was of paternal origin
(Figure 1d). Since the deletion was de novo, the recurrence
possibility of the deletion in the next pregnancy of the
couple is theoretically low. In accordance with the predic-
tion, the prenatal genetic diagnosis on the amniotic fluid
cells using SNP-array indicated the following baby of the
parents did not carry the 1q25.2q31.3 deletion as well as
any other pathological genomic imbalance.
Discussion
In this study, we have identified a de novo paternal inter-
stitial deletion of chromosomal segment 1q25.2-q31.3
with a length of 20.5 Mb in an 11-year-old female present-
ing mental retardation but no apparent growth delay by
GTG banding, SNP-array and STRP analysis.
The most common features of intermediate 1q deletion
patients are pre- and/or postnatal growth retardation, psy-
chomotor retardation, lip and palate anomalies, genital
abnormalities, small hands and feet, brachydactyly, clino-
dactyly of the fifth finger, cardiac anomalies, microcephaly,
micrognathia (Figure 2). The sizes and locations of two
deletion cases reported by Burkardt (patient 9) [10] and
Thienpont [7] are quite similar to ours. Burkardt [10]
reported an 8-year-old boy with a 22.3Mb 1q24.3-31.3 de-
letion who manifested growth retardation, psychomotor re-
tardation, microcephaly, small ears, bilateral cleft lip and
palate, micrognathia, loose nuchal skin, cryptorchidism, in-
guinal hernia, short limbs, small hands and feet, fifth finger
clinodactyly and hypotonia. Thienpont [7] identified a 20.3Figure 2 Genotypes and phenotypes of the 16 previously identified c
left. Deletions confirmed by molecular methods are illustrated with solid ho
of each deletion are listed in right box. GR, growth retardation; PR, psychom
H/F, small hands/feet; BD, brachydactyly; CL, fifth finger clinodactyly; CA, ca
negative; NA, no available; P, patient.Mb 1q25.1-31.3 deletion in an 11-year-old boy who
manifested growth retardation, psychomotor retardation,
recurrent otitis media, narrow high-arched and triangular
shaped palate, small hands and feet, fifth finger clinodactyly,
abducted thumbs, persistent finger pads, 2–3 partial syn-
dactyly of right foot, severe myopia and mild strabismus.
Unlike these two cases, the manifestations of our patient
are remarkably milder. She presented only mental retard-
ation, clinodactyly of the 5th finger and minor facial anom-
alies, but no obvious growth retardation.
Except for two cases reported by Hoglund and Milani
[4,12], severe pre- and/or postnatal growth retardation was
found in almost all of the patients with 1q25-q32 deletion.
LHX4 (LIM homeobox gene 4) and CENPL (centromeric
protein L) were suggested to be the primary candidate
genes for growth retardation in the 1q25-q32 region. Ini-
tially, several studies indicated that growth retardation was
likely attributed to the low serum GH levels resulting from
heterozygous deletion of LHX4 in patients [6-8]. Heterozy-
gous mutations of LHX4 can lead to abnormalities of pituit-
ary and cerebellum, the deficiency of growth hormone, and
then growth retardation [13]. Two individuals of 1q25q32
deletion with LHX4 loss but no CENPL loss displayed
significant growth retardation [7,11]. However, there were
several discordant reports regarding LHX4 deletion and
growth retardation [10,11]. Filges reported a female neonate
with a maternally inherited 1q25.2q25.3 deletion affecting
LHX4 but not CENPL had GH deficiency, but her mother
was phenotypically normal [11]. Intriguingly, a recent re-
port suggested CENPL deletion was responsible for growth
retardation [10], because nearly all of the documented cases
with interstitial 1q deletion harboring CENPL gene pre-
sented growth retardation. Burkardt [10] reported a cohort
of nine individuals with 1q24q25 deletions manifestingases of 1q25-32deletions. The locations of deletions are listed in the
rizontal lines and unconfirmed deletions with dotted line. Phenotypes
otor retardation; L/P, lip/palate anomalies; GA, genital abnormalities;
rdiac anomalies; MC, microcephaly; MG, micrognathia; +, positive; -,
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LHX4, while all of the nine deletions showed a loss of
CENPL. CENPL, encoding centromeric protein L, has been
proved to play an important role in assembling a functional
kinetochore and mitosis process [14], but the mechanism
underlying CENPL deletion and growth retardation remain
elusive. Taken together, CENPL heterozygous deletion ex-
hibited a full penetrance to growth retardation, while LHX4
deletion displayed an incomplete penetrance. Two patients
with 1q25q32 deletion didn’t exhibit growth retardation
[4,12], may due to the fact that their deleted regions en-
compassed neither LHX4 nor CENPL. Likewise, the normal
growth in our patient was probably due to the fact that
CENPL gene did not locate in the deleted region.
Mental retardation is the most frequent manifestation
of 1q25-32 deletion patients, but the causative genes have
not been identified. Based on the genotype-phenotype ana-
lysis, we proposed a critical region at 1q25.2 (chr1:174.5-
177.6 Mb, build 36) with a length of 3.1 Mb may account
for mental retardation. Eleven postnatal cases with 1q25-
32 deletion containing the proposed critical region dis-
played apparent mental retardation (Figure 2), while two of
the remaining three 1q25-32 deletions outside of the crit-
ical region exhibited mild mental retardation [4,12] and an-
other case of neonate is absent from mental retardation
[11]. Twenty-four genes located in the critical region, in-
cluding 7 OMIM genes (ASTN1, RASAL2, ANGPTL1,
FAM20B, TOR3A, ABL2, SOAT1). ASTN1 (Astrotactin 1),
the only one reported to be involved in the brain devel-
opment, is essential for glial-guided migration in the brain
cortex [15]. ASTN1 mutations were probably responsible
for a spectrum of cortical malformations including lis-
sencephaly, pachygyria, abnormally thick cortex, enlarged
lateral ventricles, hypoplasia of the corpus callosum/cere-
bellum in human [16]. Mice with null ASTN1 showed
smaller sizes of cerebella, poorer balance and coordin-
ation, reduction in migration rates [17]. Of the eleven
postnatal deletion cases harboring ASTN1 [2,3,6-8,10], six
displayed brain structure malformations [2,3,7,10], four
were normal by MRI analysis [8,10], and the remaining
one is unknown. We concluded that heterozygous ASTN1
deletion could be an important cause of the mental retard-
ation in 1q25-32 deletion patients.
Clinodactyly 5th finger was a common clinical feature
of 1q25q32 deletion cases. PRG4 (proteoglycan 4) encodes
a secreted glycoprotein Lubricin, which exists in synovial
fluid and the surfaces of articular cartilage, protecting the
cartilage surfaces [18]. Homozygous PRG4 mutations in
human lead to CACP (autosomal recessive camptodactyly-
arthropathy-coxa vara-pericarditis syndrome) [19], while
mice with null PRG4 alleles (PRG4−/−) exhibited morpho-
logic joints changes such as joints swelling and flexion
deformity of the hind paws [18]. Two of four previously
reported postnatal patients with PRG4 deletion manifestedjoint abnormalities [8,10]. Though PRG4 haploinsuffi-
ciency showed a strong association with skeletal abnormal-
ities in 1q25-32 deletion patients, there was no direct
evidence linking the PRG4 deletion and clinodactyly 5th
finger to date.
In this study, we determined the paternal origin of the
deletion by SNP genotypes comparison and STRP tests.
As far as we know, 7 intermediate 1q deletions (including
ours) were tested by microsatellite analysis to investigate
the origin of the genomic deletion. Only one deletion [3]
was derived from mother, the remaining six [4-6,8,12]
were all of paternal origins. However, distinctive features
between the 1q25-32 deletion patients who have different
parental origin were not observed. This phenomenon co-
incides with previous reports on other symptoms resulted
from loss of heterozygosity in this region, which didn’t
find imprinted genes either [20,21]. To our best know-
ledge, no imprinted gene has been found in the region of
1q25-32 yet. These findings indicate a possible irrelevance
between the clinical manifestations and parental origin of
1q25-32 deletion.
Conclusion
In this study, using SNP-array, we characterized a 1q25-32
deletion case with mental retardation but no significant
growth delay. SNP-array and microsatellite analysis revealed
the deletion was derived from the father. Our study pro-
vided another essential case for further genotype-phenotype
correlation studies. However, the mechanisms underlying
mental retardation resulting from 1q25-32 deletion are far
from clear, more related cases as well as functional genome




GTG-banding chromosome analyses at 500 band reso-
lution were performed on the peripheral blood lympho-
cytes from the patient and her parents according to the
standard techniques.
SNP-array
Human cyto12 SNP-array (Illumina, USA) comprising
around 300,000 SNPs was applied for whole genome
scan on the patient and parents. SNP-array experiments
were carried out as previously described [22], molecu-
lar karyotype and SNP genotype analysis was performed
by KaryoStudio V 1.3.11(Illumina) and GenomeStudio
V2011.1(Illumina) respectively.
STRP
To confirm the parental origin of the deleted 1q25.2q31.3
fragment, STRP analysis was performed following a previ-
ously described protocol [23]. Three STRP markers with
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1q25q32 region were applied.
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